Zentalis Pharmaceuticals, Inc. - ZNTL

SEC FilingsOur ZNTL Tweets

About Gravity Analytica

Recent News

  • 06.04.2025 - Jefferies Global Life Sciences Conference
  • 06.04.2025 - Jefferies Global Life Sciences Conference
  • 06.02.2025 - Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • 06.02.2025 - Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • 05.27.2025 - TD Cowen
  • 05.27.2025 - TD Cowen
  • 05.20.2025 - H.C. Wainwright 3rd Annual BioConnect Investor Conference
  • 05.20.2025 - H.C. Wainwright 3rd Annual BioConnect Investor Conference
  • 05.20.2025 - H.C. Wainwright 3rd Annual BioConnect Investor Conference
  • 05.20.2025 - H.C. Wainwright 3rd Annual BioConnect Investor Conference

Recent Filings

  • 05.23.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
  • 05.20.2025 - 8-K Current report
  • 05.14.2025 - S-8 Securities to be offered to employees in employee benefit plans
  • 05.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 05.14.2025 - 8-K Current report
  • 05.14.2025 - EX-99.1 EX-99.1
  • 05.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors